Search

5 Oct 2012: He adds that he is wary of neuroscience research being used to bolster traditional gender stereotypes. ... Joining him in the Gender difference: nature vs nurture debate on 30th October are Dr Laura Nelson, who did her PhD in neuroscience at the

11 Jun 2024: Their results, published in the journal Nature Neuroscience, suggest that an interplay between the brain’s prefrontal cortex and hippocampus allows us to imagine future outcomes to guide our decisions. ... Reference:. Kristopher T. Jensen, Guillaume

25 Jun 2024: I am grateful to my PhD students, postdoctoral fellows and colleagues for their collaboration."</p> <p><strong>Professor Christine Holt,</strong>Professor of Developmental Neuroscience, receives a CBE for services to ... Neuroscience. Professor Holtsaid:

20 Nov 2023: Spatially embedded recurrent neural networks reveal widespread links between structural and functional neuroscience findings. ... Nature Machine Intelligence; 20 Nov 2023; DOI: 10.1038/s42256-023-00748-9.

1 Feb 2008: Orchestrating brainactivity. Cover photograph of Dr Máté Lengyel 'in search of lost memories' by Dr Quentin Huysand Dr Máté Lengyel, with kind permission of Nature Neuroscience.Edited by Louise Walsh.Designed ... Research in areas such aspsychology,

16 Mar 2015: Michael Anderson. The research, published today in Nature Neuroscience, is the first to isolate the adaptive forgetting mechanism in the human brain. ... Nature Neuroscience; 16 March 2015. The text in this work is licensed under a Creative Commons

22 Jul 2013: The study, which looked at myelin regeneration in human tissue samples and in mice, is published in Nature Neuroscience and was funded by the MS Society, the Wellcome Trust and the

20 Sep 2006: Cambridge Neuroscience. NEUROSCIENCE. Neuroscience – breaking down the barriers. NOBEL WINNERS AT CAMBRIDGE. ... RESEARCH HORIZONS | October 2006 | 13. NEUROSCIENCE. Image: Nature magazine.

21 Oct 2011: models and published in Nature Neuroscience in January 2011. ... An effective treatment for halting the destruction of oligodendrocytes, alemtuzumab (Campath), was developed in Cambridge by Professor Alastair Compston and Dr Alasdair Coles at the

6 Dec 2010: The study, funded by the MS Society in the UK and the National Multiple Sclerosis Society in America, is published in Nature Neuroscience.